Global Drug-Eluting Balloon Catheters Market Growth 2026-2032
The global Drug-Eluting Balloon Catheters market size is predicted to grow from US$ 1487 million in 2025 to US$ 3521 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.
Drug-eluting balloon catheters (often referred to as drug-coated balloon catheters, DCB) are endovascular angioplasty balloons coated with an antiproliferative drug plus an excipient/carrier system. During angioplasty, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to inhibit neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic concept is ?leave nothing behind,? avoiding the long-term burden of permanent implants and enabling flexible future treatment options, increasingly integrated with lesion-preparation tools and intravascular imaging to support more refined vascular repair.In 2025, global Drug-eluting balloon catheters production reached approximately1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Growth is driven by two structural forces: a shift from implant-centric to repair-centric care, where DCBs address restenosis and reintervention pain points with a ?leave nothing behind? proposition; and a clearer evidence/regulatory boundary that improves hospital-level adoption confidence. The FDA?s updated assessment on paclitaxel-coated devices for PAD strengthens predictability around long-term safety considerations. Meanwhile, leading medtech companies continue to position DCB portfolios as a contributor to peripheral/vascular growth in annual reporting, signaling an evolution from an adjunct option toward a more standardized toolset.
The hurdle is scaling with reproducibility and compliance. As drug-device combination products, DCBs are highly sensitive to coating integrity, particulate control, dose consistency, and stability?where process drift can translate into outsized clinical and access risk. In parallel, cost containment and procurement reforms elevate quality systems, supply assurance, and cost efficiency as decisive differentiators. In China, national-level centralized procurement and published outcomes accelerate a more rules-based, scale-driven competitive phase.
Demand is consolidating around repeatable techniques and bundled solutions. Hospitals increasingly prioritize lower repeat interventions, pathway efficiency, and stable long-term outcomes?driving more routine combination of DCBs with lesion preparation tools, specialty balloons, and intravascular imaging (IVUS/OCT). In peripheral and dialysis access settings where recurrence is common, the preference to avoid repeat implants and preserve future options further reinforces the ?leave nothing behind? value narrative.
Upstream advantage is defined by integrated ?materials-coating-validation? capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements, drug APIs (paclitaxel or limus agents) and excipient systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Because requirements on biocompatibility and change control are stringent, medical-grade traceability, clean manufacturing, and robust change management at the supplier level directly shape yield, release consistency, and global compliance efficiency for OEMs.
LP Information, Inc. (LPI) ' newest research report, the ?Drug-Eluting Balloon Catheters Industry Forecast? looks at past sales and reviews total world Drug-Eluting Balloon Catheters sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug-Eluting Balloon Catheters sales for 2026 through 2032. With Drug-Eluting Balloon Catheters sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Eluting Balloon Catheters industry.
This Insight Report provides a comprehensive analysis of the global Drug-Eluting Balloon Catheters landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Eluting Balloon Catheters portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug-Eluting Balloon Catheters market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Eluting Balloon Catheters and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Eluting Balloon Catheters.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Eluting Balloon Catheters market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Drug-eluting balloon catheters (often referred to as drug-coated balloon catheters, DCB) are endovascular angioplasty balloons coated with an antiproliferative drug plus an excipient/carrier system. During angioplasty, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to inhibit neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic concept is ?leave nothing behind,? avoiding the long-term burden of permanent implants and enabling flexible future treatment options, increasingly integrated with lesion-preparation tools and intravascular imaging to support more refined vascular repair.In 2025, global Drug-eluting balloon catheters production reached approximately1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Growth is driven by two structural forces: a shift from implant-centric to repair-centric care, where DCBs address restenosis and reintervention pain points with a ?leave nothing behind? proposition; and a clearer evidence/regulatory boundary that improves hospital-level adoption confidence. The FDA?s updated assessment on paclitaxel-coated devices for PAD strengthens predictability around long-term safety considerations. Meanwhile, leading medtech companies continue to position DCB portfolios as a contributor to peripheral/vascular growth in annual reporting, signaling an evolution from an adjunct option toward a more standardized toolset.
The hurdle is scaling with reproducibility and compliance. As drug-device combination products, DCBs are highly sensitive to coating integrity, particulate control, dose consistency, and stability?where process drift can translate into outsized clinical and access risk. In parallel, cost containment and procurement reforms elevate quality systems, supply assurance, and cost efficiency as decisive differentiators. In China, national-level centralized procurement and published outcomes accelerate a more rules-based, scale-driven competitive phase.
Demand is consolidating around repeatable techniques and bundled solutions. Hospitals increasingly prioritize lower repeat interventions, pathway efficiency, and stable long-term outcomes?driving more routine combination of DCBs with lesion preparation tools, specialty balloons, and intravascular imaging (IVUS/OCT). In peripheral and dialysis access settings where recurrence is common, the preference to avoid repeat implants and preserve future options further reinforces the ?leave nothing behind? value narrative.
Upstream advantage is defined by integrated ?materials-coating-validation? capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements, drug APIs (paclitaxel or limus agents) and excipient systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Because requirements on biocompatibility and change control are stringent, medical-grade traceability, clean manufacturing, and robust change management at the supplier level directly shape yield, release consistency, and global compliance efficiency for OEMs.
LP Information, Inc. (LPI) ' newest research report, the ?Drug-Eluting Balloon Catheters Industry Forecast? looks at past sales and reviews total world Drug-Eluting Balloon Catheters sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug-Eluting Balloon Catheters sales for 2026 through 2032. With Drug-Eluting Balloon Catheters sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Eluting Balloon Catheters industry.
This Insight Report provides a comprehensive analysis of the global Drug-Eluting Balloon Catheters landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Eluting Balloon Catheters portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug-Eluting Balloon Catheters market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Eluting Balloon Catheters and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Eluting Balloon Catheters.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Eluting Balloon Catheters market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Coronary Artery Disease Drug-Eluting Balloon Catheters
- Peripheral Vascular Disease Drug-Eluting Balloon Catheters
- In-Stent Restenosi
- De Novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Catheterization Laboratories
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- B. Braun
- Medtronic
- Boston Scientific
- BD
- Yinyi Biotechnology
- Acotec
- Philips
- Lepu Medical
- Eurocor
- MicroPort Medical
- Teleflex
- What is the 10-year outlook for the global Drug-Eluting Balloon Catheters market?
- What factors are driving Drug-Eluting Balloon Catheters market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doDrug-Eluting Balloon Catheters market opportunities vary by end market size?
- How does Drug-Eluting Balloon Catheters break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Eluting Balloon Catheters Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug-Eluting Balloon Catheters by Country/Region, 2021, 2025 & 2032
2.2 Drug-Eluting Balloon Catheters Segment by Type
2.2.1 Coronary Artery Disease Drug-Eluting Balloon Catheters
2.2.2 Peripheral Vascular Disease Drug-Eluting Balloon Catheters
2.2.3 Drug-Eluting Balloon Catheters Sales by Type
2.2.3.1 Global Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
2.2.3.2 Global Drug-Eluting Balloon Catheters Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Drug-Eluting Balloon Catheters Sale Price by Type (2021-2026)
2.3 Drug-Eluting Balloon Catheters Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Drug-Eluting Balloon Catheters Sales by Use Scenario
2.3.4.1 Global Drug-Eluting Balloon Catheters Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Drug-Eluting Balloon Catheters Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Drug-Eluting Balloon Catheters Sale Price by Use Scenario (2021-2026)
2.4 Drug-Eluting Balloon Catheters Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Drug-Eluting Balloon Catheters Sales by Balloon Platform Mechanics
2.4.4.1 Global Drug-Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Drug-Eluting Balloon Catheters Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Drug-Eluting Balloon Catheters Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Drug-Eluting Balloon Catheters Segment by Application
2.5.1 Hospitals and Clinics
2.5.2 Ambulatory Surgical Centers
2.5.3 Catheterization Laboratories
2.5.4 Drug-Eluting Balloon Catheters Sales by Application
2.5.4.1 Global Drug-Eluting Balloon Catheters Sale Market Share by Application (2021-2026)
2.5.4.2 Global Drug-Eluting Balloon Catheters Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Drug-Eluting Balloon Catheters Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug-Eluting Balloon Catheters Breakdown Data by Company
3.1.1 Global Drug-Eluting Balloon Catheters Annual Sales by Company (2021-2026)
3.1.2 Global Drug-Eluting Balloon Catheters Sales Market Share by Company (2021-2026)
3.2 Global Drug-Eluting Balloon Catheters Annual Revenue by Company (2021-2026)
3.2.1 Global Drug-Eluting Balloon Catheters Revenue by Company (2021-2026)
3.2.2 Global Drug-Eluting Balloon Catheters Revenue Market Share by Company (2021-2026)
3.3 Global Drug-Eluting Balloon Catheters Sale Price by Company
3.4 Key Manufacturers Drug-Eluting Balloon Catheters Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Eluting Balloon Catheters Product Location Distribution
3.4.2 Players Drug-Eluting Balloon Catheters Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG-ELUTING BALLOON CATHETERS BY GEOGRAPHIC REGION
4.1 World Historic Drug-Eluting Balloon Catheters Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug-Eluting Balloon Catheters Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug-Eluting Balloon Catheters Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug-Eluting Balloon Catheters Market Size by Country/Region (2021-2026)
4.2.1 Global Drug-Eluting Balloon Catheters Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug-Eluting Balloon Catheters Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug-Eluting Balloon Catheters Sales Growth
4.4 APAC Drug-Eluting Balloon Catheters Sales Growth
4.5 Europe Drug-Eluting Balloon Catheters Sales Growth
4.6 Middle East & Africa Drug-Eluting Balloon Catheters Sales Growth
5 AMERICAS
5.1 Americas Drug-Eluting Balloon Catheters Sales by Country
5.1.1 Americas Drug-Eluting Balloon Catheters Sales by Country (2021-2026)
5.1.2 Americas Drug-Eluting Balloon Catheters Revenue by Country (2021-2026)
5.2 Americas Drug-Eluting Balloon Catheters Sales by Type (2021-2026)
5.3 Americas Drug-Eluting Balloon Catheters Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Eluting Balloon Catheters Sales by Region
6.1.1 APAC Drug-Eluting Balloon Catheters Sales by Region (2021-2026)
6.1.2 APAC Drug-Eluting Balloon Catheters Revenue by Region (2021-2026)
6.2 APAC Drug-Eluting Balloon Catheters Sales by Type (2021-2026)
6.3 APAC Drug-Eluting Balloon Catheters Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Eluting Balloon Catheters by Country
7.1.1 Europe Drug-Eluting Balloon Catheters Sales by Country (2021-2026)
7.1.2 Europe Drug-Eluting Balloon Catheters Revenue by Country (2021-2026)
7.2 Europe Drug-Eluting Balloon Catheters Sales by Type (2021-2026)
7.3 Europe Drug-Eluting Balloon Catheters Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Eluting Balloon Catheters by Country
8.1.1 Middle East & Africa Drug-Eluting Balloon Catheters Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug-Eluting Balloon Catheters Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug-Eluting Balloon Catheters Sales by Type (2021-2026)
8.3 Middle East & Africa Drug-Eluting Balloon Catheters Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Eluting Balloon Catheters
10.3 Manufacturing Process Analysis of Drug-Eluting Balloon Catheters
10.4 Industry Chain Structure of Drug-Eluting Balloon Catheters
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Eluting Balloon Catheters Distributors
11.3 Drug-Eluting Balloon Catheters Customer
12 WORLD FORECAST REVIEW FOR DRUG-ELUTING BALLOON CATHETERS BY GEOGRAPHIC REGION
12.1 Global Drug-Eluting Balloon Catheters Market Size Forecast by Region
12.1.1 Global Drug-Eluting Balloon Catheters Forecast by Region (2027-2032)
12.1.2 Global Drug-Eluting Balloon Catheters Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug-Eluting Balloon Catheters Forecast by Type (2027-2032)
12.7 Global Drug-Eluting Balloon Catheters Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.1.3 B. Braun Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.2.3 Medtronic Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.3.3 Boston Scientific Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.4.3 BD Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotechnology
13.5.1 Yinyi Biotechnology Company Information
13.5.2 Yinyi Biotechnology Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.5.3 Yinyi Biotechnology Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotechnology Main Business Overview
13.5.5 Yinyi Biotechnology Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.6.3 Acotec Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Philips
13.7.1 Philips Company Information
13.7.2 Philips Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.7.3 Philips Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Philips Main Business Overview
13.7.5 Philips Latest Developments
13.8 Lepu Medical
13.8.1 Lepu Medical Company Information
13.8.2 Lepu Medical Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.8.3 Lepu Medical Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lepu Medical Main Business Overview
13.8.5 Lepu Medical Latest Developments
13.9 Eurocor
13.9.1 Eurocor Company Information
13.9.2 Eurocor Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.9.3 Eurocor Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Eurocor Main Business Overview
13.9.5 Eurocor Latest Developments
13.10 MicroPort Medical
13.10.1 MicroPort Medical Company Information
13.10.2 MicroPort Medical Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.10.3 MicroPort Medical Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort Medical Main Business Overview
13.10.5 MicroPort Medical Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.11.3 Teleflex Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Eluting Balloon Catheters Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug-Eluting Balloon Catheters by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug-Eluting Balloon Catheters by Country/Region, 2021, 2025 & 2032
2.2 Drug-Eluting Balloon Catheters Segment by Type
2.2.1 Coronary Artery Disease Drug-Eluting Balloon Catheters
2.2.2 Peripheral Vascular Disease Drug-Eluting Balloon Catheters
2.2.3 Drug-Eluting Balloon Catheters Sales by Type
2.2.3.1 Global Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
2.2.3.2 Global Drug-Eluting Balloon Catheters Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Drug-Eluting Balloon Catheters Sale Price by Type (2021-2026)
2.3 Drug-Eluting Balloon Catheters Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Drug-Eluting Balloon Catheters Sales by Use Scenario
2.3.4.1 Global Drug-Eluting Balloon Catheters Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Drug-Eluting Balloon Catheters Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Drug-Eluting Balloon Catheters Sale Price by Use Scenario (2021-2026)
2.4 Drug-Eluting Balloon Catheters Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Drug-Eluting Balloon Catheters Sales by Balloon Platform Mechanics
2.4.4.1 Global Drug-Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Drug-Eluting Balloon Catheters Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Drug-Eluting Balloon Catheters Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Drug-Eluting Balloon Catheters Segment by Application
2.5.1 Hospitals and Clinics
2.5.2 Ambulatory Surgical Centers
2.5.3 Catheterization Laboratories
2.5.4 Drug-Eluting Balloon Catheters Sales by Application
2.5.4.1 Global Drug-Eluting Balloon Catheters Sale Market Share by Application (2021-2026)
2.5.4.2 Global Drug-Eluting Balloon Catheters Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Drug-Eluting Balloon Catheters Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug-Eluting Balloon Catheters Breakdown Data by Company
3.1.1 Global Drug-Eluting Balloon Catheters Annual Sales by Company (2021-2026)
3.1.2 Global Drug-Eluting Balloon Catheters Sales Market Share by Company (2021-2026)
3.2 Global Drug-Eluting Balloon Catheters Annual Revenue by Company (2021-2026)
3.2.1 Global Drug-Eluting Balloon Catheters Revenue by Company (2021-2026)
3.2.2 Global Drug-Eluting Balloon Catheters Revenue Market Share by Company (2021-2026)
3.3 Global Drug-Eluting Balloon Catheters Sale Price by Company
3.4 Key Manufacturers Drug-Eluting Balloon Catheters Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Eluting Balloon Catheters Product Location Distribution
3.4.2 Players Drug-Eluting Balloon Catheters Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG-ELUTING BALLOON CATHETERS BY GEOGRAPHIC REGION
4.1 World Historic Drug-Eluting Balloon Catheters Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug-Eluting Balloon Catheters Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug-Eluting Balloon Catheters Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug-Eluting Balloon Catheters Market Size by Country/Region (2021-2026)
4.2.1 Global Drug-Eluting Balloon Catheters Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug-Eluting Balloon Catheters Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug-Eluting Balloon Catheters Sales Growth
4.4 APAC Drug-Eluting Balloon Catheters Sales Growth
4.5 Europe Drug-Eluting Balloon Catheters Sales Growth
4.6 Middle East & Africa Drug-Eluting Balloon Catheters Sales Growth
5 AMERICAS
5.1 Americas Drug-Eluting Balloon Catheters Sales by Country
5.1.1 Americas Drug-Eluting Balloon Catheters Sales by Country (2021-2026)
5.1.2 Americas Drug-Eluting Balloon Catheters Revenue by Country (2021-2026)
5.2 Americas Drug-Eluting Balloon Catheters Sales by Type (2021-2026)
5.3 Americas Drug-Eluting Balloon Catheters Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Eluting Balloon Catheters Sales by Region
6.1.1 APAC Drug-Eluting Balloon Catheters Sales by Region (2021-2026)
6.1.2 APAC Drug-Eluting Balloon Catheters Revenue by Region (2021-2026)
6.2 APAC Drug-Eluting Balloon Catheters Sales by Type (2021-2026)
6.3 APAC Drug-Eluting Balloon Catheters Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Eluting Balloon Catheters by Country
7.1.1 Europe Drug-Eluting Balloon Catheters Sales by Country (2021-2026)
7.1.2 Europe Drug-Eluting Balloon Catheters Revenue by Country (2021-2026)
7.2 Europe Drug-Eluting Balloon Catheters Sales by Type (2021-2026)
7.3 Europe Drug-Eluting Balloon Catheters Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Eluting Balloon Catheters by Country
8.1.1 Middle East & Africa Drug-Eluting Balloon Catheters Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug-Eluting Balloon Catheters Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug-Eluting Balloon Catheters Sales by Type (2021-2026)
8.3 Middle East & Africa Drug-Eluting Balloon Catheters Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Eluting Balloon Catheters
10.3 Manufacturing Process Analysis of Drug-Eluting Balloon Catheters
10.4 Industry Chain Structure of Drug-Eluting Balloon Catheters
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Eluting Balloon Catheters Distributors
11.3 Drug-Eluting Balloon Catheters Customer
12 WORLD FORECAST REVIEW FOR DRUG-ELUTING BALLOON CATHETERS BY GEOGRAPHIC REGION
12.1 Global Drug-Eluting Balloon Catheters Market Size Forecast by Region
12.1.1 Global Drug-Eluting Balloon Catheters Forecast by Region (2027-2032)
12.1.2 Global Drug-Eluting Balloon Catheters Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug-Eluting Balloon Catheters Forecast by Type (2027-2032)
12.7 Global Drug-Eluting Balloon Catheters Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.1.3 B. Braun Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.2.3 Medtronic Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.3.3 Boston Scientific Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.4.3 BD Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi Biotechnology
13.5.1 Yinyi Biotechnology Company Information
13.5.2 Yinyi Biotechnology Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.5.3 Yinyi Biotechnology Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yinyi Biotechnology Main Business Overview
13.5.5 Yinyi Biotechnology Latest Developments
13.6 Acotec
13.6.1 Acotec Company Information
13.6.2 Acotec Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.6.3 Acotec Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Acotec Main Business Overview
13.6.5 Acotec Latest Developments
13.7 Philips
13.7.1 Philips Company Information
13.7.2 Philips Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.7.3 Philips Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Philips Main Business Overview
13.7.5 Philips Latest Developments
13.8 Lepu Medical
13.8.1 Lepu Medical Company Information
13.8.2 Lepu Medical Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.8.3 Lepu Medical Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lepu Medical Main Business Overview
13.8.5 Lepu Medical Latest Developments
13.9 Eurocor
13.9.1 Eurocor Company Information
13.9.2 Eurocor Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.9.3 Eurocor Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Eurocor Main Business Overview
13.9.5 Eurocor Latest Developments
13.10 MicroPort Medical
13.10.1 MicroPort Medical Company Information
13.10.2 MicroPort Medical Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.10.3 MicroPort Medical Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 MicroPort Medical Main Business Overview
13.10.5 MicroPort Medical Latest Developments
13.11 Teleflex
13.11.1 Teleflex Company Information
13.11.2 Teleflex Drug-Eluting Balloon Catheters Product Portfolios and Specifications
13.11.3 Teleflex Drug-Eluting Balloon Catheters Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Teleflex Main Business Overview
13.11.5 Teleflex Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug-Eluting Balloon Catheters Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug-Eluting Balloon Catheters Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Coronary Artery Disease Drug-Eluting Balloon Catheters
Table 4. Major Players of Peripheral Vascular Disease Drug-Eluting Balloon Catheters
Table 5. Global Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 6. Global Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Table 7. Global Drug-Eluting Balloon Catheters Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug-Eluting Balloon Catheters Revenue Market Share by Type (2021-2026)
Table 9. Global Drug-Eluting Balloon Catheters Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Drug-Eluting Balloon Catheters Sales by Use Scenario (2021-2026) & (K Units)
Table 14. Global Drug-Eluting Balloon Catheters Sales Market Share by Use Scenario (2021-2026)
Table 15. Global Drug-Eluting Balloon Catheters Revenue by Use Scenario (2021-2026) & ($ million)
Table 16. Global Drug-Eluting Balloon Catheters Revenue Market Share by Use Scenario (2021-2026)
Table 17. Global Drug-Eluting Balloon Catheters Sale Price by Use Scenario (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Drug-Eluting Balloon Catheters Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 22. Global Drug-Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 23. Global Drug-Eluting Balloon Catheters Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 24. Global Drug-Eluting Balloon Catheters Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 25. Global Drug-Eluting Balloon Catheters Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 26. Global Drug-Eluting Balloon Catheters Sale by Application (2021-2026) & (K Units)
Table 27. Global Drug-Eluting Balloon Catheters Sale Market Share by Application (2021-2026)
Table 28. Global Drug-Eluting Balloon Catheters Revenue by Application (2021-2026) & ($ million)
Table 29. Global Drug-Eluting Balloon Catheters Revenue Market Share by Application (2021-2026)
Table 30. Global Drug-Eluting Balloon Catheters Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Drug-Eluting Balloon Catheters Sales by Company (2021-2026) & (K Units)
Table 32. Global Drug-Eluting Balloon Catheters Sales Market Share by Company (2021-2026)
Table 33. Global Drug-Eluting Balloon Catheters Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Drug-Eluting Balloon Catheters Revenue Market Share by Company (2021-2026)
Table 35. Global Drug-Eluting Balloon Catheters Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Drug-Eluting Balloon Catheters Producing Area Distribution and Sales Area
Table 37. Players Drug-Eluting Balloon Catheters Products Offered
Table 38. Drug-Eluting Balloon Catheters Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Drug-Eluting Balloon Catheters Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Drug-Eluting Balloon Catheters Sales Market Share Geographic Region (2021-2026)
Table 43. Global Drug-Eluting Balloon Catheters Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Drug-Eluting Balloon Catheters Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Drug-Eluting Balloon Catheters Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Drug-Eluting Balloon Catheters Sales Market Share by Country/Region (2021-2026)
Table 47. Global Drug-Eluting Balloon Catheters Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Drug-Eluting Balloon Catheters Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Drug-Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 50. Americas Drug-Eluting Balloon Catheters Sales Market Share by Country (2021-2026)
Table 51. Americas Drug-Eluting Balloon Catheters Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 53. Americas Drug-Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 54. APAC Drug-Eluting Balloon Catheters Sales by Region (2021-2026) & (K Units)
Table 55. APAC Drug-Eluting Balloon Catheters Sales Market Share by Region (2021-2026)
Table 56. APAC Drug-Eluting Balloon Catheters Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 58. APAC Drug-Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 59. Europe Drug-Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 60. Europe Drug-Eluting Balloon Catheters Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 62. Europe Drug-Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Drug-Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Drug-Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Drug-Eluting Balloon Catheters
Table 68. Key Market Challenges & Risks of Drug-Eluting Balloon Catheters
Table 69. Key Industry Trends of Drug-Eluting Balloon Catheters
Table 70. Drug-Eluting Balloon Catheters Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Drug-Eluting Balloon Catheters Distributors List
Table 73. Drug-Eluting Balloon Catheters Customer List
Table 74. Global Drug-Eluting Balloon Catheters Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Drug-Eluting Balloon Catheters Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Drug-Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Drug-Eluting Balloon Catheters Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Drug-Eluting Balloon Catheters Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Drug-Eluting Balloon Catheters Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Drug-Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Drug-Eluting Balloon Catheters Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Drug-Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Drug-Eluting Balloon Catheters Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Drug-Eluting Balloon Catheters Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Drug-Eluting Balloon Catheters Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Drug-Eluting Balloon Catheters Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Drug-Eluting Balloon Catheters Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. B. Braun Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 90. B. Braun Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Medtronic Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 94. Medtronic Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 95. Medtronic Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Medtronic Main Business
Table 97. Medtronic Latest Developments
Table 98. Boston Scientific Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 99. Boston Scientific Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 100. Boston Scientific Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Boston Scientific Main Business
Table 102. Boston Scientific Latest Developments
Table 103. BD Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 104. BD Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 105. BD Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BD Main Business
Table 107. BD Latest Developments
Table 108. Yinyi Biotechnology Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 109. Yinyi Biotechnology Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 110. Yinyi Biotechnology Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Yinyi Biotechnology Main Business
Table 112. Yinyi Biotechnology Latest Developments
Table 113. Acotec Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 114. Acotec Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 115. Acotec Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Acotec Main Business
Table 117. Acotec Latest Developments
Table 118. Philips Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 119. Philips Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 120. Philips Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Philips Main Business
Table 122. Philips Latest Developments
Table 123. Lepu Medical Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 124. Lepu Medical Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 125. Lepu Medical Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Lepu Medical Main Business
Table 127. Lepu Medical Latest Developments
Table 128. Eurocor Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 129. Eurocor Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 130. Eurocor Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Eurocor Main Business
Table 132. Eurocor Latest Developments
Table 133. MicroPort Medical Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 134. MicroPort Medical Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 135. MicroPort Medical Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. MicroPort Medical Main Business
Table 137. MicroPort Medical Latest Developments
Table 138. Teleflex Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 139. Teleflex Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 140. Teleflex Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Teleflex Main Business
Table 142. Teleflex Latest Developments
Table 1. Drug-Eluting Balloon Catheters Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug-Eluting Balloon Catheters Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Coronary Artery Disease Drug-Eluting Balloon Catheters
Table 4. Major Players of Peripheral Vascular Disease Drug-Eluting Balloon Catheters
Table 5. Global Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 6. Global Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Table 7. Global Drug-Eluting Balloon Catheters Revenue by Type (2021-2026) & ($ million)
Table 8. Global Drug-Eluting Balloon Catheters Revenue Market Share by Type (2021-2026)
Table 9. Global Drug-Eluting Balloon Catheters Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of In-Stent Restenosi
Table 11. Major Players of De Novo
Table 12. Major Players of Small Vessel
Table 13. Global Drug-Eluting Balloon Catheters Sales by Use Scenario (2021-2026) & (K Units)
Table 14. Global Drug-Eluting Balloon Catheters Sales Market Share by Use Scenario (2021-2026)
Table 15. Global Drug-Eluting Balloon Catheters Revenue by Use Scenario (2021-2026) & ($ million)
Table 16. Global Drug-Eluting Balloon Catheters Revenue Market Share by Use Scenario (2021-2026)
Table 17. Global Drug-Eluting Balloon Catheters Sale Price by Use Scenario (2021-2026) & (US$/Unit)
Table 18. Major Players of Semi-/Compliant
Table 19. Major Players of Non-compliant
Table 20. Major Players of Other
Table 21. Global Drug-Eluting Balloon Catheters Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 22. Global Drug-Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 23. Global Drug-Eluting Balloon Catheters Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 24. Global Drug-Eluting Balloon Catheters Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 25. Global Drug-Eluting Balloon Catheters Sale Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 26. Global Drug-Eluting Balloon Catheters Sale by Application (2021-2026) & (K Units)
Table 27. Global Drug-Eluting Balloon Catheters Sale Market Share by Application (2021-2026)
Table 28. Global Drug-Eluting Balloon Catheters Revenue by Application (2021-2026) & ($ million)
Table 29. Global Drug-Eluting Balloon Catheters Revenue Market Share by Application (2021-2026)
Table 30. Global Drug-Eluting Balloon Catheters Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Drug-Eluting Balloon Catheters Sales by Company (2021-2026) & (K Units)
Table 32. Global Drug-Eluting Balloon Catheters Sales Market Share by Company (2021-2026)
Table 33. Global Drug-Eluting Balloon Catheters Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Drug-Eluting Balloon Catheters Revenue Market Share by Company (2021-2026)
Table 35. Global Drug-Eluting Balloon Catheters Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Drug-Eluting Balloon Catheters Producing Area Distribution and Sales Area
Table 37. Players Drug-Eluting Balloon Catheters Products Offered
Table 38. Drug-Eluting Balloon Catheters Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Drug-Eluting Balloon Catheters Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Drug-Eluting Balloon Catheters Sales Market Share Geographic Region (2021-2026)
Table 43. Global Drug-Eluting Balloon Catheters Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Drug-Eluting Balloon Catheters Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Drug-Eluting Balloon Catheters Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Drug-Eluting Balloon Catheters Sales Market Share by Country/Region (2021-2026)
Table 47. Global Drug-Eluting Balloon Catheters Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Drug-Eluting Balloon Catheters Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Drug-Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 50. Americas Drug-Eluting Balloon Catheters Sales Market Share by Country (2021-2026)
Table 51. Americas Drug-Eluting Balloon Catheters Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 53. Americas Drug-Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 54. APAC Drug-Eluting Balloon Catheters Sales by Region (2021-2026) & (K Units)
Table 55. APAC Drug-Eluting Balloon Catheters Sales Market Share by Region (2021-2026)
Table 56. APAC Drug-Eluting Balloon Catheters Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 58. APAC Drug-Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 59. Europe Drug-Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 60. Europe Drug-Eluting Balloon Catheters Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 62. Europe Drug-Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Drug-Eluting Balloon Catheters Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Drug-Eluting Balloon Catheters Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Drug-Eluting Balloon Catheters Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Drug-Eluting Balloon Catheters
Table 68. Key Market Challenges & Risks of Drug-Eluting Balloon Catheters
Table 69. Key Industry Trends of Drug-Eluting Balloon Catheters
Table 70. Drug-Eluting Balloon Catheters Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Drug-Eluting Balloon Catheters Distributors List
Table 73. Drug-Eluting Balloon Catheters Customer List
Table 74. Global Drug-Eluting Balloon Catheters Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Drug-Eluting Balloon Catheters Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Drug-Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Drug-Eluting Balloon Catheters Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Drug-Eluting Balloon Catheters Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Drug-Eluting Balloon Catheters Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Drug-Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Drug-Eluting Balloon Catheters Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Drug-Eluting Balloon Catheters Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Drug-Eluting Balloon Catheters Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Drug-Eluting Balloon Catheters Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Drug-Eluting Balloon Catheters Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Drug-Eluting Balloon Catheters Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Drug-Eluting Balloon Catheters Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. B. Braun Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 90. B. Braun Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Medtronic Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 94. Medtronic Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 95. Medtronic Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Medtronic Main Business
Table 97. Medtronic Latest Developments
Table 98. Boston Scientific Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 99. Boston Scientific Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 100. Boston Scientific Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Boston Scientific Main Business
Table 102. Boston Scientific Latest Developments
Table 103. BD Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 104. BD Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 105. BD Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. BD Main Business
Table 107. BD Latest Developments
Table 108. Yinyi Biotechnology Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 109. Yinyi Biotechnology Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 110. Yinyi Biotechnology Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Yinyi Biotechnology Main Business
Table 112. Yinyi Biotechnology Latest Developments
Table 113. Acotec Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 114. Acotec Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 115. Acotec Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Acotec Main Business
Table 117. Acotec Latest Developments
Table 118. Philips Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 119. Philips Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 120. Philips Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Philips Main Business
Table 122. Philips Latest Developments
Table 123. Lepu Medical Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 124. Lepu Medical Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 125. Lepu Medical Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Lepu Medical Main Business
Table 127. Lepu Medical Latest Developments
Table 128. Eurocor Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 129. Eurocor Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 130. Eurocor Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Eurocor Main Business
Table 132. Eurocor Latest Developments
Table 133. MicroPort Medical Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 134. MicroPort Medical Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 135. MicroPort Medical Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. MicroPort Medical Main Business
Table 137. MicroPort Medical Latest Developments
Table 138. Teleflex Basic Information, Drug-Eluting Balloon Catheters Manufacturing Base, Sales Area and Its Competitors
Table 139. Teleflex Drug-Eluting Balloon Catheters Product Portfolios and Specifications
Table 140. Teleflex Drug-Eluting Balloon Catheters Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Teleflex Main Business
Table 142. Teleflex Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug-Eluting Balloon Catheters
Figure 2. Drug-Eluting Balloon Catheters Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Eluting Balloon Catheters Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug-Eluting Balloon Catheters Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug-Eluting Balloon Catheters Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug-Eluting Balloon Catheters Sales Market Share by Country/Region (2025)
Figure 10. Drug-Eluting Balloon Catheters Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Coronary Artery Disease Drug-Eluting Balloon Catheters
Figure 12. Product Picture of Peripheral Vascular Disease Drug-Eluting Balloon Catheters
Figure 13. Global Drug-Eluting Balloon Catheters Sales Market Share by Type in 2026
Figure 14. Global Drug-Eluting Balloon Catheters Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Drug-Eluting Balloon Catheters Sales Market Share by Use Scenario in 2026
Figure 19. Global Drug-Eluting Balloon Catheters Revenue Market Share by Use Scenario (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Global Drug-Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics in 2026
Figure 24. Global Drug-Eluting Balloon Catheters Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 25. Drug-Eluting Balloon Catheters Consumed in Hospitals and Clinics
Figure 26. Global Drug-Eluting Balloon Catheters Market: Hospitals and Clinics (2021-2026) & (K Units)
Figure 27. Drug-Eluting Balloon Catheters Consumed in Ambulatory Surgical Centers
Figure 28. Global Drug-Eluting Balloon Catheters Market: Ambulatory Surgical Centers (2021-2026) & (K Units)
Figure 29. Drug-Eluting Balloon Catheters Consumed in Catheterization Laboratories
Figure 30. Global Drug-Eluting Balloon Catheters Market: Catheterization Laboratories (2021-2026) & (K Units)
Figure 31. Global Drug-Eluting Balloon Catheters Sale Market Share by Application (2025)
Figure 32. Global Drug-Eluting Balloon Catheters Revenue Market Share by Application in 2026
Figure 33. Drug-Eluting Balloon Catheters Sales by Company in 2026 (K Units)
Figure 34. Global Drug-Eluting Balloon Catheters Sales Market Share by Company in 2026
Figure 35. Drug-Eluting Balloon Catheters Revenue by Company in 2026 ($ millions)
Figure 36. Global Drug-Eluting Balloon Catheters Revenue Market Share by Company in 2026
Figure 37. Global Drug-Eluting Balloon Catheters Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Drug-Eluting Balloon Catheters Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Drug-Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 40. Americas Drug-Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 41. APAC Drug-Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 42. APAC Drug-Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 43. Europe Drug-Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 44. Europe Drug-Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Drug-Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Drug-Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 47. Americas Drug-Eluting Balloon Catheters Sales Market Share by Country in 2026
Figure 48. Americas Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Figure 49. Americas Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 50. Americas Drug-Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 51. United States Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Drug-Eluting Balloon Catheters Sales Market Share by Region in 2026
Figure 56. APAC Drug-Eluting Balloon Catheters Revenue Market Share by Region (2021-2026)
Figure 57. APAC Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 58. APAC Drug-Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 59. China Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 63. India Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Drug-Eluting Balloon Catheters Sales Market Share by Country in 2026
Figure 67. Europe Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Figure 68. Europe Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 69. Europe Drug-Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 70. Germany Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 71. France Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Drug-Eluting Balloon Catheters Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Drug-Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 78. Egypt Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Drug-Eluting Balloon Catheters in 2026
Figure 84. Manufacturing Process Analysis of Drug-Eluting Balloon Catheters
Figure 85. Industry Chain Structure of Drug-Eluting Balloon Catheters
Figure 86. Channels of Distribution
Figure 87. Global Drug-Eluting Balloon Catheters Sales Market Forecast by Region (2027-2032)
Figure 88. Global Drug-Eluting Balloon Catheters Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Drug-Eluting Balloon Catheters Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Drug-Eluting Balloon Catheters Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Drug-Eluting Balloon Catheters Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Drug-Eluting Balloon Catheters Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Drug-Eluting Balloon Catheters
Figure 2. Drug-Eluting Balloon Catheters Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Eluting Balloon Catheters Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug-Eluting Balloon Catheters Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug-Eluting Balloon Catheters Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug-Eluting Balloon Catheters Sales Market Share by Country/Region (2025)
Figure 10. Drug-Eluting Balloon Catheters Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Coronary Artery Disease Drug-Eluting Balloon Catheters
Figure 12. Product Picture of Peripheral Vascular Disease Drug-Eluting Balloon Catheters
Figure 13. Global Drug-Eluting Balloon Catheters Sales Market Share by Type in 2026
Figure 14. Global Drug-Eluting Balloon Catheters Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of In-Stent Restenosi
Figure 16. Product Picture of De Novo
Figure 17. Product Picture of Small Vessel
Figure 18. Global Drug-Eluting Balloon Catheters Sales Market Share by Use Scenario in 2026
Figure 19. Global Drug-Eluting Balloon Catheters Revenue Market Share by Use Scenario (2021-2026)
Figure 20. Product Picture of Semi-/Compliant
Figure 21. Product Picture of Non-compliant
Figure 22. Product Picture of Other
Figure 23. Global Drug-Eluting Balloon Catheters Sales Market Share by Balloon Platform Mechanics in 2026
Figure 24. Global Drug-Eluting Balloon Catheters Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 25. Drug-Eluting Balloon Catheters Consumed in Hospitals and Clinics
Figure 26. Global Drug-Eluting Balloon Catheters Market: Hospitals and Clinics (2021-2026) & (K Units)
Figure 27. Drug-Eluting Balloon Catheters Consumed in Ambulatory Surgical Centers
Figure 28. Global Drug-Eluting Balloon Catheters Market: Ambulatory Surgical Centers (2021-2026) & (K Units)
Figure 29. Drug-Eluting Balloon Catheters Consumed in Catheterization Laboratories
Figure 30. Global Drug-Eluting Balloon Catheters Market: Catheterization Laboratories (2021-2026) & (K Units)
Figure 31. Global Drug-Eluting Balloon Catheters Sale Market Share by Application (2025)
Figure 32. Global Drug-Eluting Balloon Catheters Revenue Market Share by Application in 2026
Figure 33. Drug-Eluting Balloon Catheters Sales by Company in 2026 (K Units)
Figure 34. Global Drug-Eluting Balloon Catheters Sales Market Share by Company in 2026
Figure 35. Drug-Eluting Balloon Catheters Revenue by Company in 2026 ($ millions)
Figure 36. Global Drug-Eluting Balloon Catheters Revenue Market Share by Company in 2026
Figure 37. Global Drug-Eluting Balloon Catheters Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Drug-Eluting Balloon Catheters Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Drug-Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 40. Americas Drug-Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 41. APAC Drug-Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 42. APAC Drug-Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 43. Europe Drug-Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 44. Europe Drug-Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Drug-Eluting Balloon Catheters Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Drug-Eluting Balloon Catheters Revenue 2021-2026 ($ millions)
Figure 47. Americas Drug-Eluting Balloon Catheters Sales Market Share by Country in 2026
Figure 48. Americas Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Figure 49. Americas Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 50. Americas Drug-Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 51. United States Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Drug-Eluting Balloon Catheters Sales Market Share by Region in 2026
Figure 56. APAC Drug-Eluting Balloon Catheters Revenue Market Share by Region (2021-2026)
Figure 57. APAC Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 58. APAC Drug-Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 59. China Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 63. India Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Drug-Eluting Balloon Catheters Sales Market Share by Country in 2026
Figure 67. Europe Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021-2026)
Figure 68. Europe Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 69. Europe Drug-Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 70. Germany Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 71. France Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Drug-Eluting Balloon Catheters Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Drug-Eluting Balloon Catheters Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Drug-Eluting Balloon Catheters Sales Market Share by Application (2021-2026)
Figure 78. Egypt Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Drug-Eluting Balloon Catheters Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Drug-Eluting Balloon Catheters in 2026
Figure 84. Manufacturing Process Analysis of Drug-Eluting Balloon Catheters
Figure 85. Industry Chain Structure of Drug-Eluting Balloon Catheters
Figure 86. Channels of Distribution
Figure 87. Global Drug-Eluting Balloon Catheters Sales Market Forecast by Region (2027-2032)
Figure 88. Global Drug-Eluting Balloon Catheters Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Drug-Eluting Balloon Catheters Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Drug-Eluting Balloon Catheters Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Drug-Eluting Balloon Catheters Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Drug-Eluting Balloon Catheters Revenue Market Share Forecast by Application (2027-2032)
